Transmyocardial laser revascularization fails to prevent left ventricular functional deterioration and aneurysm formation after acute myocardial infarction in sheep  by Malekan, Ramin et al.
intuitively attractive and has precedent in reptilian
anatomy.1 Investigational studies over the past decade
consistently demonstrate that laser treatment of
ischemic myocardium relieves angina, reduces intake
of antianginal medications, and modestly increases
exercise tolerance.2,3 However, imaging and post-
mortem histologic studies fail to demonstrate enduring
patency of transmural or partial thickness channels4-7;
thus the mechanism of anginal relief remains unclear.
Demonstrations of efficacy by in vivo radionuclide
studies and positron emission tomograms are inconclu-
sive.2,3 Histologic evidence is consistent with a nonspe-
cific inflammatory response to injury.4,5,8
Laser revascularizations are designed to increase
blood flow to areas of ischemic, but viable myocytes
(ie, hibernating myocardium). Hibernating myocardium
is difficult to model in animals5 and not easily nor reli-
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ably detected in patients9; therefore most investigators
use coronary arterial occlusion or ischemia/reperfusion
animal models. In dogs and pigs, preformed collateral
coronary vessels10,11 attenuate ischemia and thus con-
found interpretations of laser treatment.12
This study tests the hypothesis that laser revasculariza-
tion at the time of acute anteroapical myocardial infarc-
tion preserves cardiac myocytes and prevents infarct
expansion in a sheep model. This model was chosen for
several reasons. Sheep do not have preformed collateral
coronary vessels.13 Anteroapical infarctions consistently
evolve into large, discrete anteroapical aneurysms over 8
weeks.14 Serial functional studies and images of ventric-
ular morphologic condition provide sensitive and rele-
vant measures of the efficacy of laser therapy.15
Methods
Surgical protocol. Anesthesia was induced with thiopental
sodium (10 to 15 mg/kg) in 26 Q-fever negative, Dorsett
hybrid sheep, and the animals were intubated, anesthetized
with isoflurane (1.5% to 2%) in oxygen, and mechanically
ventilated (Drager and anesthesia monitor; North American
Drager, Telford, Pa). All animals received glycopyrolate (0.4
mg, intravenously) and cefazolin (1 g, intravenously) before
anesthesia. The surface electrocardiogram and brachial or
femoral arterial blood pressure were continuously monitored.
Animals were treated in compliance with NIH publication
No. 85-23 as revised in 1985.
All animals had sterile left anterolateral thoracotomy in the
fifth intercostal space. Polypropylene snares were placed
around the homonymous and second diagonal coronary arter-
ies approximately 40% from the apex. (The homonymous
artery is equivalent to the human left anterior descending
coronary artery [LAD].) The anticipated infarct area of
approximately 23% of left ventricular (LV) mass14 was
marked with an epicardial 2-0 silk suture. An ultrasonic flow
probe (Transonic Systems, Inc, Ithaca, NY) was placed
around the aortic root proximal to the origin of the brachio-
cephalic artery. Two epicardial pacemaker wires were sewn
to the left atrium. The chest was closed, and the pacing wires
and flow probe connection were exteriorized. Sheep received
cefazolin (1 g every 8 hours, intravenously) for 3 days.
Baseline data. Seven to 10 days after instrumentation, ani-
mals were anesthetized, intubated, and mechanically ventilat-
ed as before. Sheep were placed supine, and surface electro-
cardiogram and arterial blood pressure were continuously
monitored. A Swan-Ganz thermodilution catheter (131 h-7F;
Baxter Healthcare Corp, Irvine, Calif) was introduced via the
left external jugular vein for measurement of pulmonary
artery and pulmonary artery occlusion pressures. A high-
fidelity pressure transducer (Spc-350; Millar Instruments,
Inc, Houston, Tex) was inserted via the femoral or carotid
artery into the LV for continuous LV pressure monitoring.
Animals were atrially paced at 120 beats/min and were
disconnected from the ventilator for all hemodynamic
measurements.
Fig 1. A, Microscopic section of myocardium 48 hours after
infarction in a sheep that died of an arrhythmia. This animal had
transmyocardial laser perforations immediately before infarc-
tion. The area of laser channel is clearly seen. The channel is
occluded by fibrin. (Hematoxylin and eosin, original magnifi-
cation · 50.) B, Laser-treated myocardium 5 weeks after infarc-
tion. The infarction (at its edge) is nearly completely replaced
by fibrous tissue and scattered calcifications. Cardiac myofi-
broblasts predominate; a few cardiac myocyte remnants, neu-
trophils and macrophages are present in the infarct.
(Hematoxylin and eosin, original magnification · 25.) C, Laser-
treated myocardium 8 weeks after infarction. This section was
taken from the edge of the infarct. The infarct has healed as a
fibrous scar nourished by small blood vessels. Cardiac
myocytes and inflammatory cells are absent. No laser channels
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echocardiographic images were obtained through a sterile
midline or subcostal laparotomy incision15 using a 5 MHz
probe (77020A; Hewlett-Packard, Palo Alto, Calif) and were
recorded on videotape. Short-axis images at 3 levels of the
LV (approximating infarct, border zone, and remote myo-
cardium) and 2 orthogonal long-axis views were obtained.
Long-axis views were recorded during apnea and were used
to calculate end-diastolic and end-systolic cavity volumes by
biplane Simpson’s rule.16
Diastolic and systolic wall thickness of the anterior LV
wall in the area of infarction was measured before and 1 hour
and 8 weeks after infarction in all sheep. Total and cavity
areas of short-axis views also were measured in the area of
infarction at the same time points. The perimeter length of the
akinetic/dyskinetic wall segment was determined 8 weeks
after infarction in all sheep.
Stroke work. Stroke work (SW) was calculated from
simultaneous measurements of aortic flow and LV pressure17: 
Equation 1
SW (ergs) = ∫beat LVP (mm Hg) · Q (mL/sec) · dt (sec) · 1330,
where LVP is LV pressure, Q is aortic flow, and dt is the
time differential in seconds. Stroke volume (SV) is equal to
the average SV over 10 beats, where SV is calculated as in
equation 2.
Equation 2
SV (mL) = ∫beat Q (mL/sec) · dt (sec)
Measurements were repeated 5 times with 3-minute inter-
vals between data runs. Means of 5 data sets were used for
the subsequent analysis.
Slope of the SW-LV end-diastolic pressure relationship.
Global LV function was also estimated by relating SW to LV
end-diastolic pressure (LVEDP). A 50 mL Fogarty catheter
(US Catheter and Instrument Co, Glen Falls, NY) was placed
into the vena cava via the right external jugular vein with flu-
oroscopic guidance and was inflated to decrease ventricular
preload. SW was measured over the subsequent 10 beats and
plotted against LVEDP. The slope of the relationship and cor-
relation coefficient was calculated. In all cases, the correla-
tion coefficient was greater than 0.92, and typically the cor-
relation coefficient was approximately 0.99. Caval
occlusions were repeated 5 times, and the mean slope of all
the 5 measurements was recorded.
Laser revascularization and myocardial infarction.
After baseline measurements were taken, animals were ran-
domly assigned to 2 groups: control (group I, n = l2) and the
Fig 2. Long-axis views of a control heart (A) and a heart treated by transmyocardial laser perforations (B) 8
weeks after infarction. Both hearts are enlarged, and borders of the aneurysym are sharp and distinct. The
aneurysm involves the anteroapical wall, part of the septum, and a small apical portion of the right ventricle.
A B
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laser group (group II, n = 14). In the laser group before infarc-
tion, animals were placed in the right lateral decubitus posi-
tion and underwent a repeat thoracotomy through the previ-
ous incision. A total of 34 ± 4 (SD; range, 29-42) transmural
channels (approximately 4 channels per square centimeter)
were created within 15 to 20 minutes in the area of the antic-
ipated infarct, which was marked by suture with an 800-W
carbon dioxide laser and 25 to 30 J (The Heart Laser; PLC
Medical Systems, Telford, Mass). Creation of all laser chan-
nels was confirmed by appearance of pulsating bright red
blood from the left ventricle. Bleeding from channels was
controlled by either digital pressure or a superficially placed
nonabsorbable 4-0 suture.
In both groups, exteriorized snares were pulled up to pro-
duce infarction immediately after completion of laser revas-
cularization (8.9 ± 4.6 minutes). Control animals had similar
infarctions but did not undergo a second thoracotomy.
Arterial blood gases and plasma electrolytes were monitored
before and during infarction, and abnormalities were corrected.
Animals received a lidocaine bolus (l mg/kg, intravenously)
and continuous infusion at 2 mg/min. Arrhythmias were con-
trolled with lidocaine, bretylium, esmolol, and magnesium.
After the circulation stabilized, the chest was closed in layers.
Approximately 1 hour after infarction, hemodynamic and
echocardiographic measurements were repeated in both
groups. The laparotomy incision was closed, and animals
were allowed to recover.
Follow-up studies. The sheep were followed up, and identi-
cal measurements were made at 2, 5, and 8 weeks after infarc-
tion. The laparotomy incision was moved between the left and
Fig 3. Echocardiographic long-axis views of the LV of a control animal immediately before infarction (A), 1 hour
after infarction (B), and at 8 weeks (C). Immediately after infarction, the LV enlarges and the anterior wall
becomes thinner and dyskinetic. Compare these echocardiograms with Fig 4. LA, Left atrium.
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right subcostal incisions and the midline to reduce wound com-
plications. After the 8-week study, animals were killed with a
bolus of pentothal (10 mg/kg, intravenously) and potassium
chloride (80 mEq). The heart was excised, opened in the long
axis, photographed, and fixed in 10% neutral buffered forma-
lin. Infarcted myocardium was sliced at 1.5- to 2-mm intervals
perpendicular to the long axis of laser channels from epicardi-
um to endocardium. Sections were embedded in paraffin, cut
at 5 m m intervals, and stained with hematoxylin and eosin.
Trichrome stains were performed to highlight areas of fibrosis.
All sections were examined microscopically.
Statistics. Measurements are reported as means and stan-
dard deviations. Differences between the 2 groups are com-
pared by 2-way ANOVA (group, time), with Bonferroni
adjustment for repeated measures (Statistical Package for the
Social Science Program 6.0: SPSS, Inc, Chicago, Ill). If the
time effect was significant (P < .05) differences between pre-
infarction and subsequent measurements were compared by
the paired t statistic. When the group effect was significant,
differences between groups at specific times were compared
by the unpaired t statistic.
Results
Twenty-six animals (12 control, 14 laser) underwent
instrumentation and infarction. Eighteen sheep (10
control, 8 laser) completed the 8-week protocol. Two
animals in the control group and 4 animals in the laser
group died after infarction and before the 2-week study
secondary to postinfarction arrhythmias. Two animals
in the laser group died after the 5-week study; one
Fig 4. Long-axis echocardiographic views of the LV of a laser-treated animal immediately before both laser per-
forations and infarction (A), 1 hour after infarction (B), and at 8 weeks (C). Compare these echocardiograms with
Fig 3. LA, Left atrium.
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awoke with acute paraplegia; a wound infection and
pneumonia developed in the other. After weeks 5 and 6,
all animals became increasingly lethargic, experienced
basilar rales, and required markedly reduced doses of
thiopental sodium for induction of anesthesia for the 8-
week study.
None of the laser transmyocardial channels were patent
in sheep examined by histologic methods 48 hours and 5
and 8 weeks after infarction. At 48 hours, laser channels
were filled with fibrin; surrounding infarcted myocytes
remained, and only a few inflammatory cells were pre-
sent (Fig 1, A). By 5 weeks, granulation tissue with scat-
tered calcifications and a few macrophages and lympho-
cytes replaced most of the necrotic cardiac myocytes.
Laser channels were not identified, and only very small
vessels (equal to 10 to 20 m m in diameter) were present
(Fig 1, B). At 8 weeks, the infarction was completely
replaced with fibrous tissue without evidence of laser
channels (Fig l, C).
All hearts in both groups developed thin-walled
anteroapical LV aneurysms (Fig 2). Edges of the infarct
were sharply demarcated, and the size and shape of the
aneurysms were indistinguishable between groups
(Fig 2, A and B).
Echocardiograms document the evolution from
infarction to aneurysm in both groups (Figs 3 and 4).
Echocardiograms 1 hour after infarction showed dys-
kinetic bulging of the infarcted area (Figs 3, B, and 4, B)
Table I. Selected echocardiographic measurements
Group I Group II
Baseline One hour Eight weeks Baseline One hour Eight weeks
Diastolic WT (mm) 9.0 ± 1.1 8.7 ± 1.2 4.8 ± 0.3 8.0 ± 1.2 7.8 ± 1.2 4.5 ± 0.6
Systolic WT (mm) 11.3 ± 1.2 9.1 ± 3.2 10.6 ± 1.3 7.9 ± 1.3
Change from baseline, WT, diastole (%) –3.3 –46.7 –2.5 –43.8
Change from baseline, WT, systole (%) –19.5 –25.5
Diastolic CA (cm2) 7.2 ± 2.1 6.8 ± 1.7 10.2 ± 2.6 5.7 ± 1.9 4.5 ± 1.8* 9.9 ± 2.7
Systolic CA (cm2) 4.2 ± 1.8 8.1 ± 2.3 11.6 ± 3.3 3.6 ± 2.4 6.0 ± 2.0 12.9 ± 4.1
Change from baseline, CA, diastole (%) –5.6 +41.7 –21.1 +73.7
Change from baseline, CA, systole (%) +92.9 +176.2 +66.7 +258.3
Long axis perimeter, diastole (cm) 18.9 ± 1.4 19.0 ± 1.4
Long axis perimeter, systole (cm) 18.4 ± 1.3 18.1 ± 1.2
Length akinetic/dyskinetic segment (cm) 8.0 ± 1.4 8.2 ± 1.4
WT, Wall thickness; CA, cavity area. Values are from images that contain the infarcted or anticipated infarcted segment. Wall thickness measurements describe the
infarcted segment before and after infarction. At 8 weeks, there was no change in infarct wall thickness during the cardiac cycle. Values are mean ± SD. 
*P = .01, between groups; obtained by unpaired t statistic.
Table II. Hemodynamic measurements
Two-way ANOVA (P value)
Before After Two Five Eight 
Measurement Group infarct infarct* weeks* weeks weeks* Time Group Interaction
Number Control (I) 12 12 10 10 10
Laser (II) 14 14 10 10 8
Arterial pressure Control (I) 74 ± 7 63 ± 6 (.00) 69 ± 6 69 ± 4 71 ± 15 0 .14 .35
(mm Hg) Laser (II) 77 ± 7 64 ± 8 (.00) 72 ± 7 76.6 ± 11 69 ± 12
LVESP (mm Hg) Control (I) 88 ± 9 81 ± 9 81 ± 9 79 ± 7 79 ± 7 .02 .86 .35
Laser (II) 86 ± 7 78 ± 11 80 ± 10 86 ± 12 77 ± 12
LVEDP (mm Hg) Control (I) 1.8 ± 1.0 7.9 ± 3.5 (.00) 6.4 ± 5.4 (.02) 5.8 ± 1.9 6.1 ± 3.0 (.03) 0 .12 .27
Laser (II) 2.7 ± 2.9 6.0 ± 3.5 4.0 ± 1.7 4.0 ± 3.7 6.5 ± 2.9
CVP (mm Hg) Control (I) 9.9 ± 2.7 12.1 ± 3.1 8.5 ± 2.6 7.5 ± 2.0 8.3 ± 2.8 0 .83 .4
Laser (II) 9.7 ± 2.9 10.4 ± 2.3 8.5 ± 3.8 9.0 ± 3.2 8.6 ± 2.3
Cardiac output Control (I) 2.3 ± 0.7 2.2 ± 0.9 1.9 ± 0.7 1.9 ± 0.4 1.6 ± 0.6 .21 .67 .33
(L/min) Laser (II) 2.2 ± 0.5 2.0 ± 0.6 1.9 ± 0.3 2.1 ± 0.6 2.1 ± 0.7
LVESP, LV end systolic pressure; CVP, central venous pressure. Values are mean ± SD of measured hemodynamic parameters. P values were tabulated for time and
group effect, and interaction (error) was tabulated by 2-way ANOVA with Bonferroni adjustment for repeated measures. 
*Significant P values within groups (baseline vs subsequent values) obtained by paired t statistic are shown in parentheses.
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that progressed to LV aneurysm within 8 weeks in all
animals (Figs 3, C, and 4, C). Immediately after infarc-
tion, systolic wall thickness of the infarct decreased in
both groups (Table I). Wall thickness of the infarct fur-
ther decreased by 8 weeks, and there were no significant
differences between groups for wall thickness at any
time. The LV cavity area during diastole decreased
immediately after infarction in the short-axis view that
included the infarcted segment in both groups (Table I).
The systolic cavity area increased immediately after
infarction in both groups. By 8 weeks, diastolic and sys-
tolic cavity areas were immensely greater than at base-
line. With one exception, there were no significant dif-
ferences between groups in LV cavity area. At 8 weeks,
the long-axis perimeter from aortic valve around the
apex to the base of the heart and the length of the aki-
netic/dyskinetic segment were nearly identical in the 2
groups of sheep (Table I). At no time could the 2 groups
of animals be differentiated on the basis of echocardio-
graphic images.
Hemodynamic measurements for the 2 groups of ani-
mals at each time point are presented in Table II. By 2-
way ANOVA there were significant differences over
time in all recorded parameters in both groups, except
cardiac output. Immediately after infarction, there was
a significant reduction in mean arterial pressure in both
groups. LVEDP increased in both groups but was not
statistically significant in the laser group.
Two-way ANOVA indicated a significant group effect
for end-systolic volume (ESV) and end-diastolic vol-
ume (EDV; P = .03 and P = .02, respectively; Table III).
However, there was no significant difference between
the 2 groups at any time period for any variable mea-
sured with the unpaired t statistic (P > .05; Fig 5). By 2-
way ANOVA there were significant differences over
time for EDV and ESV, ejection fraction, SW, and SW-
LVEDP slope (Table III). As the data indicate, 2 weeks
after infarction there was a significant increase in EDV
and ESV compared with the baseline, and these para-
meters continued to increase over the next 6 weeks,
indicating ongoing LV cavity enlargement.
Ejection fraction and SW progressively decreased in
both groups after infarction (Table III). Ejection frac-
tion was significantly less than baseline by 2 weeks in
both groups (Fig 6); SW progressively decreased after
infarction (Fig 7, Table III). SV does not significantly
change after infarction in either group. The slope of
SW-LVEDP decreased significantly in both groups
after infarction (P = .001 for time), but none of the val-
ues at specific time points are significantly less than
baseline by paired t test.
Discussion
This study fails to demonstrate any evidence of
revascularization by transmyocardial laser perfora-
tions. Within 1 hour of coronary arterial occlusion,
echocardiograms of laser-treated and control sheep
documented loss of systolic wall thickening, infarct
thinning, and dyskinesis of the anterior LV wall at the
level of infarction. The magnitude of change was the
same in both groups even though all laser perforations
were made within 10 to 25 minutes of the onset of
Table III. Geometric and functional measurements
Two-way ANOVA (P value)
Before After Two Five Eight 
Measurement Group infarct infarct weeks* weeks* weeks* Time Group Interaction
Number Control (I) 12 12 10 10 10
Laser (II) 14 14 10 10 8
End diastolic Control (I) 53.3 ± 11.1 65.2 ± 17.2 87.8 ± 19.4 (.00) 89.3 ± 12.6 (.00) 98.3 ± 16.0 (.00) 0 .02 .76
volume (mL) Laser (II) 49.2 ± 9.7 54.3 ± 16.2 72.4 ± 16.6 (.02) 85.4 ± 21.4 (.00) 93.0 ± 25.3 (.00)
End systolic Control (I) 27.9 ± 6.8 38.5 ± 9.9 64.5 ± 19.3 (.00) 64.2 ± 12.4 (.00) 75.9 ± 18.8 (.00) 0 .03 .48
volume (mL) Laser (II) 26.1 ± 6.9 30.8 ± 11.5 48.4 ± 16.8 (.01) 64.1 ± 21.8 (.00) 69.6 ± 22.6 (.00)
Ejection Control (I) 47.4 ± 8.2 40.4 ± 7.4 27.6 ± 8.7 (.00) 28.3 ± 7.3 (.00) 23.4 ± 5.8 (.00) 0 .15 .51
fraction (%) Laser (II) 47.3 ± 6.7 44.3 ± 9.2 34.7 ± 10.1 (.01) 27.0 ± 9.7 (.00) 25.9 ± 6.7 (.00)
SV (mL) Control (I) 19.4 ± 6.4 18.7 ± 7.2 16.2 ± 6.2 16.1 ± 3.4 13.4 ± 5.2 .2 .66 .35
Laser (II) 18.4 ± 4.1 16.7 ± 4.8 15.5 ± 2.7 17.8 ± 4.9 17.6 ± 5.8
SW Control (I) 240 ± 85 206 ± 80 175 ± 70 170 ± 49 138 ± 51(.01) .02 .67 .31
(ergs· 10E3) Laser (II) 216 ± 55 176 ± 67 181 ± 62 206 ± 89 178 ± 78
SW-LVEDP Control (I) 38.1 ± 14.0 25.0 ± 12.7 27.6 ± 10.6 31.2 ± 9.7 27.2 ± 10.5 0 .61 .65
slope Laser (II) 33.0 ± 15.3 20.0 ± 7.6 (.02) 26.9 ± 9.1 33.3 ± 9.9 30.5 ± 4.3
(ergs· 10E3/mm Hg)
Values are mean and SD of measured and calculated geometric and functional parameters. P values were tabulated for time and group effects, and interaction (error)
were tabulated by 2-way ANOVA with Bonferroni adjustment for repeated measures. 
*Significant P values within groups (baseline vs subsequent values) obtained by paired t statistic are shown in parentheses.
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ischemia. In 1968 Pifarré and colleagues18 concluded
that myocardial revascularization from the ventricle is
not possible on the basis of pressure measurements
made in dogs. Our observations support that conclu-
sion.
Our failure to demonstrate patent laser channels is in
agreement with previous observations4-7,19 and varies
with demonstrations of patent channels in patients by
imaging techniques20 and occasional sightings in
patients21 and animals.22,23 As previously reported in
pigs, dogs, and sheep, laser perforations produce a non-
specific inflammatory response4,5,8 that includes
increased vascularity by small (5 to 10 m m) vessels typ-
ical of granulation tissue.5,24 Specific protein markers
of angiogenesis show increased uptake in inflamed tis-
sue surrounding laser perforations but are not directly
connected with laser channels.5,24 The addition of vas-
cular endothelial growth factor injected at the time of
laser therapy does not produce channel patency in
pigs.25 Thus available data indicate that only a few, and
usually no, laser channels remain patent and that the
procedure produces a local nonspecific inflammatory
reaction that is unable to sustain cardiac myocytes.
Our serial studies also failed to demonstrate any
effect of transmyocardial laser perforations on ventric-
ular remodeling after acute anteroapical myocardial
infarction. After laser therapy, the LV remodeled into
anteroapical aneurysms of the same size and location as
observed in untreated animals. Echocardiographic
measurements showed no evidence of acute or chronic
cardiac myocyte preservation after transmyocardial
laser perforations of the infarct. In rats, Whittaker and
colleagues23,26 observed that the presence of patent
laser channels or needle channels made 2 months
before infarction were associated with reduced necro-
sis; others also reported smaller infarcts as determined
by triphenyl tetrazolium chloride staining in dogs and
sheep.22,27 The improvement in dogs was small; the
sheep study reported an unstated number of irregular,
Fig 5. Changes in LVEDV before and after infarction in both
groups. d, Control animals; s , laser-treated sheep. The mean
and SEM were plotted for data in Table III. There are no sig-
nificant differences between groups at any time. *P < .05
compared with baseline; †P < .01 compared with baseline.
Fig 6. Changes in ejection fraction (EF) before and after
infarction in both groups. There were no significant differences
between groups at any time. (Symbols are explained in Fig 5.)
Fig 7. Changes in SW in both groups before and after infarc-
tion. There were no significant differences between groups at
any time. (Symbols are explained in Fig 5.)
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patent, fibrin-lined channels observed 30 days after
laser therapy of the infarct. These studies and those of
Whittaker and colleagues sustain the possibility that
patent channels may attenuate the size of an animal
infarction; however, as noted earlier, transmyocardial
laser perforations rarely remain patent.
The present serial LV functional studies with and
without transmyocardial laser perforation are unique
because only short-term assessments of function have
been made previously in animals.22,28 Yano and col-
leagues28 found improvement in preload recruitable
SW in dogs treated by partial transmyocardial endocar-
dial laser perforations 1 to 6 hours after 90 minutes of
coronary arterial ischemia. Horvath and colleagues22
observed very slightly improved epicardial shortening
in the area of infarction 30 days after laser perforations.
Our serial studies over 8 weeks with multiple measures
of ventricular function with the chest intact are con-
vincing evidence that transmyocardial laser perfora-
tions of recently infarcted myocardium do not provide
meaningful improvement in LV function.
Demonstrations of efficacy of transmyocardial laser
perforations of ischemic myocardium, therefore, rest
primarily on clinical observations that are subject to
alternative explanations. After transmyocardial laser
“revasculariztion” of ischemic (hibernating) myocardi-
um 70% to 100% of patients experience reduced fre-
quency of angina,2,3 decreased use of antianginal med-
ication,2 and fewer subsequent hospital admissions2;
but an improvement in long-term survival has not been
documented. Exercise tolerance is increased modestly
in patients with anginal relief.3 Understandably these
results are ascribed to laser revascularization, but stud-
ies of Kwong and colleagues29 with endocardial and
epidardial laser perforations in dogs indicate that affer-
ent nerves from the heart are blocked by the procedure.
The mechanism of blockage may be related to epicar-
dial inflammation.29 The duration of afferent nerve
inhibition is not known, but the observation provides
an alternative explanation for consistent relief of angi-
na, reduction of antianginal medications, and modestly
improved exercise tolerance in patients treated by
transmyocardial laser perforations.
Imaging studies of wall motion and myocardial perfu-
sion before and after transmyocardial laser perforations
of ischemic myocardium do not provide convincing evi-
dence of improved myocardial perfusion in areas treated
by transmyocardial laser perforation. Horvath and col-
leagues3 reported experience with 13 patients and found
no improvement in ejection fraction, wall motion score,
thallium perfusion scans, or positron emission tomogra-
phy (PET), 12 months after operation, but did observe
improvement in the ratio of endocardial to epicardial
blood flow. In 11 patients, lasered wall segments evalu-
ated for myocardial perfusion at 12 months by PET were
approximately evenly divided between “improved,
worse, and same.”3 Cooley and colleagues2 reported a
decrease in perfusion defects after transmyocardial laser
perforations in an uncontrolled, multi-institutional study
of 200 patients. The average decrease in lateral wall per-
fusion defects was approximately 1 in 12 wall segments
assessed.2 These equivocal data underscore limits of
imaging technology in patients with diffuse coronary
arterial disease and are further confounded by the abili-
ty of myocardial leukocytes to take up fluorine-18-2-
deoxyglucose detected by PET scans.30
The limitations of this study are primarily two: an
infarct rather than a “hibernating” model was used and
the symptom of angina cannot be measured in animals.
Clinically, transmyocardial laser revascularization
(TMR) has been used in the setting of chronic severe
angina refractory to other forms of medical and inter-
ventional therapy. Because ours is a model of acute
coronary ischemia, the results are not directly applica-
ble to the current clinical applications of TMR therapy.
Despite these limitations, the results of this study and
careful review of the available literature support the
conclusion that transmyocardial laser perforations
cause a local nonspecific inflammatory response but do
not increase myocardial blood flow sufficiently to pre-
vent myocyte death or to alter ventricular remodeling
in the setting of an acute myocardial infarction.
We thank Ms Priscilla Hillyer and Mr Brad Richardson for
their considerable help in this study.
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Discussion
Dr Craig R. Smith (New York, NY). This study may prove
to be an interesting boundary marker in our understanding of
TMR, but for those inclined to see the findings as nails in the
coffin of the TMR concept, it is worth reviewing what we
already know. In marked contrast to what is reported here,
Maricini showed that TMR reduced deaths from 100% to 27%
in dogs whose LAD was ligated proximal to the first diagonal,
which is certainly a substantial salvage under conditions of
acute ischemia. The problem with dogs is that they have exten-
sive collaterals, unlike the sheep used in your study. By using
sheep, you have chosen a very severe model of acute ischemia
and have indeed demonstrated that TMR is not robust enough
to salvage myocardium in the absence of collaterals. If we con-
sider what is known clinically, this is not surprising. TMR is
known to carry increased risk in patients whose condition is
unstable. Nuclear scan evidence of improved perfusion, of the
sort you would think would be necessary acutely to prevent
aneurysm formation, does not usually show up for at least 3
months. All of this supports the increasingly persuasive notion
that TMR functions by stimulating angiogenesis, not by pump-
ing blood through patent channels. I presume you chose a
severe model of acute ischemia in which there are no collater-
als to test the limits of TMR, but I do not think anyone should
be too surprised by the results.
Dr Malekan. I agree with you to a point. We chose this
model because, when we started doing this study, there were
a lot of reports that the TMR channels do, in fact, stay open.
So we hypothesized that if you could induce infarction with-
in a short period of time after producing these channels and if
these channels do in fact provide the ischemic myocardium
with any blood, then the size of the infarct could be attenuated.
Moreover, if there is any other mechanism of TMR, such as
angiogenesis, then over the 8-week period we should see a
change in the natural history of the infarcted myocardium,
such as a decrease in size or a decrease in dyskinesis. This
was in fact not true.
Dr Michael Mann (Boston, Mass). It is still not quite clear
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to me what the hypothesis was behind the design of this
experiment. As has been mentioned, it is quite clear from pre-
vious work that the channels are not patent after laser injury
to the heart; however, the functional improvement that has
been seen in patients who have undergone this therapy, and
the work that has been done histologically, implies that
angiogenesis is, in fact, the mechanism of treatment. 
Now, we know that angiogenesis requires weeks to
months, really, for adequate new collateral blood vessel for-
mation to develop. What was the rationale behind using such
an acute injury approach in which the loss of myocardium
really occurs within hours to perhaps days? Once that
myocardium has suffered that acute injury, it is very unlikely
that you are going to regenerate new tissue to improve
myocardial function or help prevent aneurysm formation
without the implantation of satellite cells, as has been pro-
posed today, or other new technology. So again, if you would,
just review what the hypothesis was behind testing TMR, a
therapy for chronic ischemia, in such an acute infarction
approach. It certainly is not clinically relevant to say that we
can bring patients in 9 minutes before their myocardial
infarctions for laser treatments. I am not quite clear why you
hypothesize this angiogenesis could possibly salvage cells
that were dying within hours to days of the initial injury.
Dr Malekan. Let me reiterate that our original hypothesis
was, again, if we could provide the ischemic myocardium
immediately before infarction, with any additional blood, we
might be able to decrease the infarct size. If there is any addi-
tional mechanism at TMR, such as angiogenesis, it should
change the natural history of the infarct, decreasing the size
of the aneurysm or preventing the aneurysm formation total-
ly, but that was not the case here. Your argument incorrectly
implies that there is clear scientific evidence that angiogene-
sis is the mechanism of TMR-induced angina relief. This has
not been established. TMR denervates the myocardium, for
instance. We presented data at the American Heart Associ-
ation meeting in October 1997 suggesting that TMR-induced
“angiogenesis” may be nothing more than a nonspecific in-
flammatory response.
Dr Todd Rosengart (New York, NY). Just one quick ques-
tion to turn these arguments around. Do you have plans of
looking at a chronic model? Instead of performing a ligation
immediately after TMR, maybe repeat the experiments and
ligate 6 weeks later. I think that would address most of the
questions that are being asked today.
Dr Malekan. Creating a chronic ischemic model is not
easy. In some species there are confounding factors, such as
dogs that develop a lot of collaterals. We did try producing a
chronic ischemic model in sheep, but sheep have no collater-
al circulation, and most of the animals died 10 to 14 days
after ameroid placement. We are investigating a chronic
porcine model of coronary ischemia.
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